human proislet peptide
Peptideexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2012 (NCT01638611)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
REG3A inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- human proislet peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01933256 | Phase 1 | Aug 1, 2013 | CureDM, Profil GmbH |
| NCT01638611 | Phase 1 | Jul 1, 2012 | Celerion, CureDM |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CureDM | For profit | 2 | 2 | 1 | 2012 |
| Celerion | For profit | 1 | 0 | 1 | 2012 |
| Profil GmbH | For profit | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1